Skip to content
Screener

Tandem Diabetes Care TNDM Interest income and other income (expense), net

Interest income and other income (expense), net at other companies

Align Technology logo
Align TechnologyALGN
-$5.32M-151%
Align Technology logo
Align TechnologyALGN
-$5.32M-151%
Teads Holding Co. logo
Teads Holding Co.TEAD
-$559K-15.5%
Marchex logo
MarchexMCHX
-$174K-5,700%
Sutro Biopharma logo
Sutro BiopharmaSTRO
-$1.01M+21.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$9.87M0.0%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.29B+34.3%
Enterprise value$1.96B+46.2%
P/S1.2×+0.3×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept tndm:InterestIncomeAndOtherIncomeExpenseNet.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses158,572177,665312,794416,950
Operating loss(13,792)(51,810)(31,226)(172,688)
Other income (expense), net:
Interest income and other income, net1,225(632)4,8513,561
Interest expense(2,450)(1,905)(4,654)(3,767)
Loss from equity method investment(5,641)(3,375)(9,506)(6,917)
Total other income (expense), net(6,866)(5,912)(9,309)(7,123)
Loss before income taxes(20,658)(57,722)(40,535)(179,811)

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's interest income and other income (expense), net?
Tandem Diabetes Care (TNDM) reported interest income and other income (expense), net of $1.23M in Q2 2026.
How has Tandem Diabetes Care's interest income and other income (expense), net changed year-over-year?
Tandem Diabetes Care's interest income and other income (expense), net increased by 293.8% year-over-year, from -$632K to $1.23M.
What is the long-term trend for Tandem Diabetes Care's interest income and other income (expense), net?
Over 2 years (2023 to 2025), Tandem Diabetes Care's interest income and other income (expense), net has grown at a -37.0% compound annual growth rate (CAGR), from $22.86M to $9.09M.
What does interest income and other income (expense), net mean?
Interest income and other income (expense), net as reported by Tandem Diabetes Care, Inc..

Ask your AI about Tandem Diabetes Care's interest income and other income (expense), net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude